Rhodri King

455 total citations
17 papers, 291 citations indexed

About

Rhodri King is a scholar working on Endocrinology, Diabetes and Metabolism, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Rhodri King has authored 17 papers receiving a total of 291 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Rhodri King's work include Blood properties and coagulation (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). Rhodri King is often cited by papers focused on Blood properties and coagulation (6 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers) and Antiplatelet Therapy and Cardiovascular Diseases (2 papers). Rhodri King collaborates with scholars based in United Kingdom, Germany and Switzerland. Rhodri King's co-authors include Ramzi Ajjan, Peter J. Grant, Verena Schroeder, Christian Tiede, Katie J. Simmons, Darren C. Tomlinson, Steffen Thiel, Colin W. G. Fishwick, Jackie F. Price and Mark W. J. Strachan and has published in prestigious journals such as The Lancet, Blood and European Heart Journal.

In The Last Decade

Rhodri King

17 papers receiving 288 citations

Peers

Rhodri King

EDM

CCM

PRM

HEMAT

IMMUN

Marianne Yngen Sweden

C DAVIS United States

Xin Qian China

Takaaki Maeno Japan

Maria Mannila Sweden

R Tantillo Italy

Kun Chi China

Kristian Løkke Funck Denmark

H.-J. Hertfelder Germany

José María Pou Spain

Marianne Yngen Sweden

Rhodri King

142 ×1.4

EDM

129 ×1.8

CCM

64 ×1.1

PRM

65 ×1.1

HEMAT

36 ×0.6

IMMUN

Citations per year, relative to Rhodri King Rhodri King (= 1×) peers Marianne Yngen

Countries citing papers authored by Rhodri King

Since Specialization

Citations

This map shows the geographic impact of Rhodri King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rhodri King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rhodri King more than expected).

Fields of papers citing papers by Rhodri King

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rhodri King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rhodri King. The network helps show where Rhodri King may publish in the future.

Co-authorship network of co-authors of Rhodri King

This figure shows the co-authorship network connecting the top 25 collaborators of Rhodri King. A scholar is included among the top collaborators of Rhodri King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rhodri King. Rhodri King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Phoenix, Fladia, et al.. (2024). Changes in fibrin clot properties in patients after Roux-en-Y gastric bypass surgery. Research and Practice in Thrombosis and Haemostasis. 8(2). 102361–102361. 1 indexed citations

King, Rhodri, Katharina Schuett, Christian Tiede, et al.. (2020). Fibrinogen interaction with complement C3: a potential therapeutic target to reduce thrombosis risk. Haematologica. 106(6). 1616–1623. 18 indexed citations

Thomas, Julia, et al.. (2020). Patients with morbid obesity should not be routinely screened for Cushing's syndrome: Results of retrospective study of patients attending a specialist weight management service. Clinical Obesity. 10(3). e12358–e12358. 3 indexed citations

Kearney, Katherine J., Rhodri King, Christian Tiede, et al.. (2018). Affimer proteins as a tool to modulate fibrinolysis, stabilize the blood clot, and reduce bleeding complications. Blood. 133(11). 1233–1244. 22 indexed citations

King, Rhodri, et al.. (2017). High‐dose oral colecalciferol loading in obesity: impact of body mass index and its utility prior to bariatric surgery to treat vitamin D deficiency. Clinical Obesity. 7(2). 92–97. 12 indexed citations

King, Rhodri & Ramzi Ajjan. (2016). Hypoglycaemia, thrombosis and vascular events in diabetes. Expert Review of Cardiovascular Therapy. 14(10). 1099–1101. 16 indexed citations

King, Rhodri & Ramzi Ajjan. (2016). Vascular risk in obesity: Facts, misconceptions and the unknown. Diabetes and Vascular Disease Research. 14(1). 2–13. 23 indexed citations

King, Rhodri & Peter J. Grant. (2016). Diabetes and cardiovascular disease: pathophysiology of a life-threatening epidemic. Herz. 41(3). 184–192. 49 indexed citations

King, Rhodri, et al.. (2016). Adrenal insufficiency in asthma patients – Who is at risk?. PA4899–PA4899. 1 indexed citations

10.

King, Rhodri, Christian Tiede, Katie J. Simmons, et al.. (2015). Inhibition of complement C3 and fibrinogen interaction: a potential novel therapeutic target to reduce cardiovascular disease in diabetes. The Lancet. 385. S57–S57. 23 indexed citations

11.

Franchi, Francesco, Fabiana Rollini, Jung Rae Cho, et al.. (2015). Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel. Thrombosis and Haemostasis. 115(3). 622–631. 21 indexed citations

12.

King, Rhodri, L. Harrison, S. G. Gilbey, et al.. (2015). Diabetic hepatosclerosis: another diabetes microvascular complication?. Diabetic Medicine. 33(2). e5–7. 14 indexed citations

13.

Heß, Katharina, Saad Alzahrani, Jackie F. Price, et al.. (2014). Hypofibrinolysis in type 2 diabetes: the role of the inflammatory pathway and complement C3. Diabetologia. 57(8). 1737–1741. 40 indexed citations

14.

King, Rhodri, et al.. (2014). The fibrin network in diabetes: its role in thrombosis risk. Polskie Archiwum Medycyny Wewnętrznej. 124(11). 617–627. 8 indexed citations

15.

Ajjan, Ramzi, et al.. (2014). Plasma levels of mannan-binding lectin-associated serine proteases MASP-1 and MASP-2 are elevated in type 1 diabetes and correlate with glycaemic control. Clinical & Experimental Immunology. 180(2). 227–232. 35 indexed citations

16.

Phoenix, Fladia, Nikolaus Marx, Rhodri King, et al.. (2013). Modulation of complement C3 levels and fibrin clot structure: the role of aspirin dose. European Heart Journal. 34(suppl 1). P4881–P4881. 2 indexed citations

17.

Peacey, Steven R., et al.. (2012). The follow-up of radioiodine-treated hyperthyroid patients: should thyroid function be monitored more frequently?. PubMed. 35(1). 82–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact